Year 2018 Vol. 26 No 5




Belarusian Medical Academy of Post-Graduate Education, Minsk,
The Republic of Belarus

Objective. To evaluate the clinical efficacy of the combined method of anal condylomatosis treatment, based on laser tumor destruction and immunomodulatory therapy.
Methods. The study included 2 stages. At the first retrospective stage the analysis of 60 patients with anal condylomatosis treatment using laser and electrosurgical destruction methods was performed, immune therapy was not used. The duration of the wound epithelialization, recurrence rate were studied. In the second, prospect study 60 patients were observed; the physical methods of condyloma destruction were supplemented with the therapy of human recombinant interferon α2b and imiquimod.
Results. According to the data obtained during the study, laser and electrosurgical destruction are effective methods of anal condylomatosis treatment. Laser destruction has certain advantages: higher epithelialization rate in the area of exposure (ANOVA, p=0.00001) and fewer recurrences of the disease in terms of 2 years follow-up (Pearsons chi-squared test, χ2 = 4.89; p=0.0270). The separate use of physical methods in the treatment of this pathology leads to a much greater number of relapses compared with the complex approach, where laser and electrocoagulation destruction is supplemented with immune and antiviral treatment by human recombinant interferon α2b and imiquimod (Cochrans Q test, Q=9.591549, p = 0.022378). Also the time interval without the disease progressing was longer in this groups (Kaplan-Meier test, p=0.01528).
Conclusions. The results of the study allow us to state that the use of laser radiation for the destruction of anal condylomas has several advantages over electrocoagulation: a lower risk of recurrence, a shorter period of epithelialization of the wound. The use of immunomodulatory therapy with human recombinant interferon α2b and topical application of imiquimod significantly reduces the frequency of the disease recurrence.

Keywords: condylomatosis, anogenital warts, laser, electrosurgical destruction, interferons, imiquimod
p. 563-569 of the original issue
  1. Prilepskaia VN, Rogovskaia SI, Kondrikov NI, Sukhikh GT. Papillomavirusnaia infektsiia: diagnostika, lechenie i profilaktika. Moscow, RF: MEDpress-inform; 2007. 32 p. (in Russ.)
  2. Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis. 2008 Sep 1;47(5):610-15. doi: 10.1086/590560
  3. Narvskaia OV. Virus papillomy cheloveka. Epidemiologiia, laboratornaia diagnostika i profilaktika papillomavirusnoi infektsii. Infektsiia i Immunitet. 2011;1(1):15-22. (in Russ.)
  4. Fleischer AB Jr, Parrish CA, Glenn R, Feldman SR. Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis. 2001 Nov;28(11):643-47.
  5. Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldan K. Genital warts and cost of care in England. Sex Transm Infect. 2011 Oct;87(6):464-68. doi: 10.1136/sti.2010.048421
  6. Östensson E, Fröberg M, Leval A, Hellström AC, Bäcklund M, Zethraeus N, Andersson S. Cost of preventing, managing, and treating human papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination. PLoS One. 2015;10(9): e0139062. Published online 2015 Sep 23. doi: 10.1371/journal.pone.0139062
  7. Redklif K. Evropeiskie standarty diagnostiki i lecheniia zabolevanii, peredavaemykh polovym putem: per. s angl. Moscow, RF: Med lit; 2006. 272 p. (in Russ.)
  8. Shakhrai SV, Kudritskii DV, Gain IuM, Gain MIu. Comparative estimation of efficiency of the modern methods of invasive treatment of perianal area condylomatosis. Innovats Tekhnologii v Meditsine. 2018;(1):29-35. (in Russ.)
  9. Bencini PL, Guida S, Cazzaniga S, Pellacani G, Galimberti MG, Bencini M, Naldi L. Risk factors for recurrence after successful treatment of warts: the role of smoking habits. J Eur Acad Dermatol Venereol. 2017 Apr;31(4):712-16. doi: 10.1111/jdv.14086
  10. Volkov VG, Zakharova TV. Practice of using CO2-laser surgery in complex therapy of cervical pathology, associated with human papilloma virus. Vestn Novykh Med Tekhnologii. 2000;7(1):95-97. (in Russ.)
  11. Al-Zahrani D, Raddadi A, Massaad M, Keles S, Jabara HH, Chatila TA, Geha R. Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency. Clin Immunol. 2014 Jul;153(1):104-108. doi: 10.1016/j.clim.2014.04.005
  12. Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012 Jun;5(6):25-36.
  13. Petersen CS, Bjerring P, Larsen J, Blaakaer J, Hagdrup H, From E, Obergaard L. Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study. Genitourin Med. 1991 Apr;67(2):99-102.
Address for correspondence:
220013, The Republic of Belarus,
Minsk, P. Brovki Str., 3-3,
Belarusian Medical Academy of Post-Graduate Education,
Department of Urgent Surgery,
Tel.: +375 17 225 88 10,
Yuri M. Gain
Information about the authors:
Shakhrai Siarhei V., MD, Professor of the Department of Urgent Surgery, Belarusian Medical Academy of Post-Graduate Education, Minsk, Republic of Belarus.
Gain Yuri M., MD, Professor, Vice-Rector for Scientific Work, Belarusian Medical Academy of Post-Graduate Education, Minsk, Republic of Belarus.
Gain Mikhail Yu., PhD, Associate Professor of the Department of Urgent Surgery, Belarusian Medical Academy of Post-Graduate Education, Minsk, Republic of Belarus.
Kudrytski Dzmitry V., Post-Graduate Student of the Department of Urgent Surgery, Belarusian Medical Academy of Post-Graduate Education, Minsk, Republic of Belarus.
Contacts | ©Vitebsk State Medical University, 2007-2023